Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;34(12):15659-15674.
doi: 10.1096/fj.202002136R. Epub 2020 Nov 1.

The role of RAGE in host pathology and crosstalk between RAGE and TLR4 in innate immune signal transduction pathways

Affiliations
Review

The role of RAGE in host pathology and crosstalk between RAGE and TLR4 in innate immune signal transduction pathways

Daniel Prantner et al. FASEB J. 2020 Dec.

Abstract

Although the innate immune receptor protein, Receptor for Advanced Glycation End products (RAGE), has been extensively studied, there has been renewed interest in RAGE for its potential role in sepsis, along with a host of other inflammatory diseases of chronic, noninfectious origin. In contrast to other innate immune receptors, for example, Toll-like receptors (TLRs), that recognize ligands derived from pathogenic organisms that are collectively known as "pathogen-associated molecular patterns" (PAMPs) or host-derived "damage-associated molecular patterns" (DAMPs), RAGE has been shown to recognize a broad collection of DAMPs exclusively. Historically, these DAMPs have been shown to be pro-inflammatory in nature. Early studies indicated that the adaptor molecule, MyD88, might be important for this change. More recent studies have explored further the mechanisms underlying this inflammatory change. Overall, the newer results have shown that there is extensive crosstalk between RAGE and TLRs. The three canonical RAGE ligands, Advanced Glycation End products (AGEs), HMGB1, and S100 proteins, have all been shown to activate both TLRs and RAGE to varying degrees in order to induce inflammation in in vitro models. As with any field that delves deeply into innate signaling, obstacles of reagent purity may be a cause of some of the discrepancies in the literature, and we have found that commercial antibodies that have been widely used exhibit a high degree of nonspecificity. Nonetheless, the weight of published evidence has led us to speculate that RAGE may be physically interacting with TLRs on the cell surface to elicit inflammation via MyD88-dependent signaling.

Keywords: DAMPs; HMGB1; inflammation; toll-like receptors.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosure:

The authors declare no conflict of interest. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Institute of Allergy and Infectious Diseases.

Figures

Figure 1:
Figure 1:. RAGE ligands exhibit crosstalk between RAGE and TLR4 for innate immune signaling.
Hypothetical model of MyD88 activation by RAGE occurs through a TLR4-dependent fashion. We propose that the putative RAGE ligands; AGEs, HMGB1, and S100 proteins can activate macrophages through both TLR4 and RAGE due to a physical interaction at the cell surface to activate MyD88 downstream signaling.
Figure 2:
Figure 2:. Some commercial antibodies detect RAGE in lung lysates but not in macrophages, or detect non-specific bands in the approximate MW range of RAGE.
Lung tissue (A) from WT or RAGE−/− mice were lysed, separated by SDS-PAGE, transferred to PVDF membrane, and probed for RAGE (polyclonal antibody) or GAPDH. (B) Peritoneal macrophages from WT or RAGE−/− mice were lysed, separated by SDS-PAGE, transferred to PVDF membrane, and probed for RAGE (polyclonal antibody) or GAPDH. Western blots were carried out as described in (B) except membranes were probed with the anti-RAGE monoclonal antibodies A9 (C) or A11(D).

Similar articles

Cited by

References

    1. Neeper M, Schmidt AM, Brett J, et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992;267(21):14998–5004. - PubMed
    1. Sugaya K, Fukagawa T, Matsumoto K, et al. Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics 1994;23(2):408–19. - PubMed
    1. Yonekura H, Yamamoto Y, Sakurai S, et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 2003;370(Pt 3):1097–109. - PMC - PubMed
    1. Schlueter C, Hauke S, Flohr AM, Rogalla P, Bullerdiek J. Tissue-specific expression patterns of the RAGE receptor and its soluble forms--a result of regulated alternative splicing? Biochim Biophys Acta 2003;1630(1):1–6. - PubMed
    1. Hudson BI, Carter AM, Harja E, et al. Identification, classification, and expression of RAGE gene splice variants. FASEB J 2008;22(5):1572–80. - PubMed

Publication types

MeSH terms

Substances